Business Description
Beijing Sunho Pharmaceutical Co Ltd
SIC : 2834
ISIN : CNE100005Z47
Share Class Description:
BJSE:920017: Ordinary SharesTotal Employee Number:
588Compare
Compare
Traded in other countries / regions
920017.China IPO Date
2023-05-31Description
Beijing Sunho Pharmaceutical Co Ltd engages in the research and development, production, and sales of pharmaceutical preparations while providing CMC/CMO integrated services for pharmaceutical preparation manufacturers and drug R&D enterprises. The company produces small-volume injections, freeze-dried powder injections, hard capsules, tablets, and other products. The company's main products included: compound digestive enzyme capsules, piracetam (small injection and powder injection), and oxalic acid acetate.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 84.13 | |||||
Equity-to-Asset | 0.82 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.08 | |||||
Interest Coverage | 556.65 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 4.85 | |||||
Beneish M-Score | -3.15 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -7.2 | |||||
3-Year EBITDA Growth Rate | -7.8 | |||||
3-Year EPS without NRI Growth Rate | 1.9 | |||||
3-Year FCF Growth Rate | -17.2 | |||||
3-Year Book Growth Rate | 3.6 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 43.78 | |||||
9-Day RSI | 38.79 | |||||
14-Day RSI | 40.26 | |||||
3-1 Month Momentum % | 11.28 | |||||
6-1 Month Momentum % | -0.4 | |||||
12-1 Month Momentum % | -12.15 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.63 | |||||
Quick Ratio | 4.3 | |||||
Cash Ratio | 3.73 | |||||
Days Inventory | 129.6 | |||||
Days Sales Outstanding | 32.81 | |||||
Days Payable | 182.09 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 3.83 | |||||
Dividend Payout Ratio | 0.6 | |||||
Forward Dividend Yield % | 3.83 | |||||
5-Year Yield-on-Cost % | 3.83 | |||||
3-Year Average Share Buyback Ratio | -10.7 | |||||
Shareholder Yield % | 3.94 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 70.62 | |||||
Operating Margin % | 20.1 | |||||
Net Margin % | 17.55 | |||||
EBITDA Margin % | 19.78 | |||||
FCF Margin % | 15.18 | |||||
OCF Margin % | 36.41 | |||||
ROE % | 7.06 | |||||
ROA % | 5.86 | |||||
ROIC % | 12.01 | |||||
3-Year ROIIC % | 124.12 | |||||
ROC (Joel Greenblatt) % | 16.65 | |||||
ROCE % | 7.4 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 16.85 | |||||
PE Ratio without NRI | 15.56 | |||||
Shiller PE Ratio | 18.95 | |||||
Price-to-Owner-Earnings | 34.54 | |||||
PS Ratio | 2.96 | |||||
PB Ratio | 1.19 | |||||
Price-to-Tangible-Book | 1.24 | |||||
Price-to-Free-Cash-Flow | 21.35 | |||||
Price-to-Operating-Cash-Flow | 8.41 | |||||
EV-to-EBIT | 8.33 | |||||
EV-to-EBITDA | 8.33 | |||||
EV-to-Revenue | 1.65 | |||||
EV-to-FCF | 11.88 | |||||
Price-to-GF-Value | 1.03 | |||||
Price-to-Projected-FCF | 1 | |||||
Price-to-Graham-Number | 0.93 | |||||
| Price-to-Net-Current-Asset-Value | 2.78 | |||||
| Price-to-Net-Cash | 3.93 | |||||
Earnings Yield (Greenblatt) % | 12 | |||||
FCF Yield % | 4.68 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Beijing Sunho Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 656.319 | ||
| EPS (TTM) (Â¥) | 0.935 | ||
| Beta | 1.0636 | ||
| 3-Year Sharpe Ratio | 0.47 | ||
| 3-Year Sortino Ratio | 0.87 | ||
| Volatility % | 20.55 | ||
| 14-Day RSI | 40.26 | ||
| 14-Day ATR (Â¥) | 0.497742 | ||
| 20-Day SMA (Â¥) | 16.2265 | ||
| 12-1 Month Momentum % | -12.15 | ||
| 52-Week Range (Â¥) | 14.79 - 21.86 | ||
| Shares Outstanding (Mil) | 123.89 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Beijing Sunho Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Beijing Sunho Pharmaceutical Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.600000 Cash Dividend | 2026-06-11 | -- | ||
| CNY 0.160000 Cash Dividend | 2025-06-18 | -- |
Show
Entries
Beijing Sunho Pharmaceutical Co Ltd Frequently Asked Questions
What is Beijing Sunho Pharmaceutical Co Ltd(BJSE:920017)'s stock price today?
The current price of BJSE:920017 is ¥15.67. The 52 week high of BJSE:920017 is ¥21.86 and 52 week low is ¥14.79.
When is next earnings date of Beijing Sunho Pharmaceutical Co Ltd(BJSE:920017)?
The next earnings date of Beijing Sunho Pharmaceutical Co Ltd(BJSE:920017) is .
Does Beijing Sunho Pharmaceutical Co Ltd(BJSE:920017) pay dividends? If so, how much?
The Dividend Yield %  of Beijing Sunho Pharmaceutical Co Ltd(BJSE:920017) is 3.83% (As of Today), Highest Dividend Payout Ratio of Beijing Sunho Pharmaceutical Co Ltd(BJSE:920017) was 0.6. The lowest was 0.17. And the median was 0.24. The  Forward Dividend Yield % of Beijing Sunho Pharmaceutical Co Ltd(BJSE:920017) is 3.83%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers